1.Duration of Implantable Cardiac Monitoring and Detection of Atrial Fibrillation in Ischemic Stroke Patients: A Systematic Review and Meta-Analysis
Georgios TSIVGOULIS ; Aristeidis H KATSANOS ; Martin KÖHRMANN ; Valeria CASO ; Fabienne PERREN ; Lina PALAIODIMOU ; Spyridon DEFTEREOS ; Sotirios GIANNOPOULOS ; John ELLUL ; Christos KROGIAS ; Dimitris MAVRIDIS ; Sokratis TRIANTAFYLLOU ; Anne W ALEXANDROV ; Peter D SCHELLINGER ; Andrei V ALEXANDROV
Journal of Stroke 2019;21(3):302-311
BACKGROUND AND PURPOSE: Current guidelines do not provide firm directions on atrial fibrillation (AF) screening after ischemic stroke (IS). We sought to investigate the association of implantable cardiac monitoring (ICM) duration with the yield of AF detection in IS patients. METHODS: We included studies reporting AF detection rates by ICM in IS patients with negative initial AF screening. We excluded studies reporting prolonged cardiac monitoring with devices other than ICM, not providing AF detection rates or monitoring duration, and reporting overlapping data for the same population. The random-effects model was used for all pooled estimates and meta-regression analyses. RESULTS: We included 28 studies (4,531 patients, mean age 65 years). In meta-regression analyses, the proportion of AF detection by ICM was independently associated with monitoring duration (coefficient=0.015; 95% confidence interval [CI], 0.005 to 0.024) and mean patient age (coefficient=0.009; 95% CI, 0.003 to 0.015). No associations were detected with other patient characteristics, including IS subtype (cryptogenic vs. embolic stroke of undetermined source) or time from IS onset to CM implantation. In subgroup analyses, significant differences (P<0.001) in the AF detection rates were found for ICM duration (<6 months: 5% [95% CI, 3% to 6%]; ≥6 and ≤12 months: 21% [95% CI, 16% to 25%]; >12 and ≤24 months: 26% [95% CI, 22% to 31%]; >24 months: 34% [95% CI, 29% to 39%]). CONCLUSIONS: Extended duration of ICM monitoring and increased patient age are factors that substantially increase AF detection in IS patients with initial negative AF screening.
Atrial Fibrillation
;
Humans
;
Mass Screening
;
Stroke
2.Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke
Georgios TSIVGOULIS ; Maher SAQQUR ; Vijay K. SHARMA ; Alejandro BRUNSER ; Jürgen EGGERS ; Robert MIKULIK ; Aristeidis H. KATSANOS ; Theodore N. SERGENTANIS ; Konstantinos VADIKOLIAS ; Fabienne PERREN ; Marta RUBIERA ; Reza BAVARSAD SHAHRIPOUR ; Huy Thang NGUYEN ; Patricia MARTÍNEZ-SÁNCHEZ ; Apostolos SAFOURIS ; Ioannis HELIOPOULOS ; Ashfaq SHUAIB ; Carol DERKSEN ; Konstantinos VOUMVOURAKIS ; Theodora PSALTOPOULOU ; Anne W. ALEXANDROV ; Andrei V. ALEXANDROV ;
Journal of Stroke 2020;22(1):130-140
Background:
and Purpose Although onset-to-treatment time is associated with early clinical recovery in acute ischemic stroke (AIS) patients treated with intravenous tissue plasminogen activator (tPA), the effect of the timing of tPA-induced recanalization on functional outcomes remains debatable.
Methods:
We conducted a multicenter, prospective observational cohort study to determine whether early (within 1-hour from tPA-bolus) complete or partial recanalization assessed during 2-hour real-time transcranial Doppler monitoring is associated with improved outcomes in patients with proximal occlusions. Outcome events included dramatic clinical recovery (DCR) within 2 and 24-hours from tPA-bolus, 3-month mortality, favorable functional outcome (FFO) and functional independence (FI) defined as modified Rankin Scale (mRS) scores of 0–1 and 0–2 respectively.
Results:
We enrolled 480 AIS patients (mean age 66±15 years, 60% men, baseline National Institutes of Health Stroke Scale score 15). Patients with early recanalization (53%) had significantly (P<0.001) higher rates of DCR at 2-hour (54% vs. 10%) and 24-hour (63% vs. 22%), 3-month FFO (67% vs. 28%) and FI (81% vs. 39%). Three-month mortality rates (6% vs. 17%) and distribution of 3-month mRS scores were significantly lower in the early recanalization group. After adjusting for potential confounders, early recanalization was independently associated with higher odds of 3-month FFO (odds ratio [OR], 6.19; 95% confidence interval [CI], 3.88 to 9.88) and lower likelihood of 3-month mortality (OR, 0.34; 95% CI, 0.17 to 0.67). Onset to treatment time correlated to the elapsed time between tPA-bolus and recanalization (unstandardized linear regression coefficient, 0.13; 95% CI, 0.06 to 0.19).
Conclusions
Earlier tPA treatment after stroke onset is associated with faster tPA-induced recanalization. Earlier onset-to-recanalization time results in improved functional recovery and survival in AIS patients with proximal intracranial occlusions.